Biotech

Abattis Closes on the Acquisition of Animo Wellness Corporation

VANCOUVER, BRITISH COLUMBIA: Highlights: - Definitive share exchange agreement for acquisition is closed - Acquisition includes 75 Canadian licenses and NPN numbers issued by Health Canada ...

Helix Biopharma Corp. Announces Q2 2012 Results

AURORA, ON: Confirms Reconstituted Board of Directors ...

Threshold Pharmaceuticals' TH-302 Receives Orphan Drug Designation in the European Union for the Treatment of Soft Tissue Sarcoma

SOUTH SAN FRANCISCO, CA: ...

Agennix AG to Participate in 5th Kempen & Co Healthcare/Life Sciences Conference

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: ...

MethylGene Reports Fourth Quarter and Full Year 2011 Financial Results

MONTREAL, QUEBEC: ...

Helix BioPharma Corp. Announces Agreed Changes to the Board of Directors and Settlement With Concerned Shareholders

AURORA, ON: ...

Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2011 Financial Results

SOUTH SAN FRANCISCO, CA: ...

Marina Biotech and ProNAi Therapeutics Announce License Agreement for the Development of DNAi-Based Therapeutics

BOTHELL, WA and ANN ARBOR, MI: ProNAi Therapeutics Will Develop Oncology-Focused Compounds Utilizing Its Proprietary DNAi Technology Combined With Marina Biotech's Novel SMARTICLES(R) Liposomal Delivery Technology ...

Sunshine Heart Announces FDA Completes Review of C-Pulse(R) Feasibility Data

SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN: Next Up: Submission of U.S. Pivotal Trial Protocol ...

Medivation, Inc. Prices $225 Million 2.625% Convertible Senior Notes Due 2017

SAN FRANCISCO, CA: ...